{"": [73, 81, 0, 82, 1507, 0], "INTRODUCTION": [1508, 3100, 0], "SARS-CoV-2 ELISpot T-cell immunity test": [3110, 5952, 0], "T-cell immunity following vaccination": [5953, 8331, 0], "High throughput whole blood T-cell assay": [8332, 12164, 0], "Vaccine responses by demographics": [12165, 13910, 0], "T-cell immunity to SARS-CoV-2 variants following vaccination": [13911, 17383, 0], "RESULTS": [3101, 17383, 1], "DISCUSSION": [17384, 22786, 0], "Convalescent cohort:": [22955, 23574, 0], "Healthy control cohorts:": [23575, 24263, 0], "Vaccination cohorts:": [24264, 25530, 0], "Study Participants": [22796, 25530, 1], "Blood collection and processing": [25531, 26036, 0], "Peptide pools and protein": [26037, 27168, 0], "IFN\u03b3 ELISpot assay": [27169, 28864, 0], "Selection of ELISpot SFU threshold for positivity": [28865, 29656, 0], "Whole blood assay and IFN\u03b3 ELISA": [29657, 30624, 0], "Selection of IFN\u03b3 ELISA IU/ml threshold for positivity": [30625, 31307, 0], "ELISA for detection of antibody response to SARS-CoV-2 spike protein": [31308, 32089, 0], "Variant modeling": [32090, 32930, 0], "Statistical analysis": [32931, 33760, 0], "METHODS": [22787, 33760, 1], "Extended Data": [33761, 35347, 0]}